NNVC240816C2500
- 0.22
- +0.07+46.67%
Nanoviricides Newsroom
Express News | NanoViricides Shares Are Trading Higher After the Company Announced It Discussed Its Development Program for NV-387
NanoViricides Discusses Lead Program and Next Steps | NYSE-A:NNVC
NanoViricides Is Well Positioned With Its Clinical and Pre-Clinical Pipeline and Unique Host-Mimetic, Virus Killing, Technology Platform Intending To Revolutionize Treatment of Viral Infections
NanoViricides Hails Broad Potential of Lead Antiviral Drug as It Prepares to Begin First Phase II Trial | NYSE-A:NNVC
NanoViricides Reports Promising Results for NV-387 in Influenza A H3N2 Mouse Model | NYSE-A:NNVC
A Novel Broad-Spectrum Antiviral Against Influenza A Viruses, NV-387, Could Be an Important Weapon to Fight Bird Flu H5N1, Says NanoViricides
Express News | NanoViricides Shares Are Trading Higher After the Company Announced That It Ultra-broad-spectrum Antiviral NV-387 Was Found to Be Effective in Protecting Lungs From Damage in a Lethally Infected Influenza A H3N2 Mouse Model
Why Jabil Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
12 Health Care Stocks Moving In Thursday's Intraday Session
Express News | NanoViricides Inc: NV-387 Treatment Resulted in Significant Reduction in Mucus Load in Lungs
Express News | NanoViricides Inc: NV-387 Treatment Significantly Protected Lungs of Balb-C Mice Lethally Infected With Influenza a/H3N2 Virus
Express News | NanoViricides Inc: NV-387 Treatment Resulted in Significant Reduction in Lung Infiltration and Lung Cell Death
Express News | NanoViricides Inc: Ultra-Broad-Spectrum Antiviral NV-387, Clinical Phase II Stage Drug Candidate, Was Found Effective in Protecting Lungs From Damage
Express News | Nanoviricides Reports That The Ultra-broad-spectrum Antiviral NV-387, A Phase 2 Stage Drug Candidate, Was Found To Be Effective In Protecting Lungs From Damage In A Lethally Infected Influenza H3N2 Mouse Model
A Novel Broad-Spectrum Antiviral Against Influenza A Viruses, NV-387, Is Effective in Protecting Lungs From Damage in Lethally Infected Animal Model
Why AMMO Shares Are Trading Lower By Over 19%? Here Are Other Stocks Moving In Friday's Mid-Day Session
12 Health Care Stocks Moving In Friday's Intraday Session
12 Health Care Stocks Moving In Wednesday's Intraday Session
Bullish Trend In NanoViricides (NNVC) Shares Following Promising Clinical Findings
Molecular MOLN Preclinical Data; NanoViricides NNVC Animal Model Data